SPAM1 Antibody [mFluor Violet 450 SE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-45852MFV450
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
ELISA, Western Blot
Label
mFluor Violet 450 SE (Excitation = 406 nm, Emission = 445 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
sperm adhesion molecule 1(PH-20 hyaluronidase, zona pellucida binding). (Uniprot# P38567)
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for SPAM1 Antibody [mFluor Violet 450 SE]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SPAM1
Long Name
Sperm Adhesion Molecule 1
Alternate Names
HYA1, HYAL3, HYAL5, PH20, SPAG15
Gene Symbol
SPAM1
Additional SPAM1 Products
Product Documents for SPAM1 Antibody [mFluor Violet 450 SE]
Product Specific Notices for SPAM1 Antibody [mFluor Violet 450 SE]
mFluor(TM) is a trademark of AAT Bioquest, Inc. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...